GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **3751 - 3775** of **4050** in total

« First

‹ Prev

…

147

148

149

150

151

152

153

154

155

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgA	Patient 1	10	moderate	G92823JK	391
IgA	Patient 1	22	moderate	G92823JK	398
IgA	Patient 1	6	moderate	G92823JK	358
IgG	Patient 1	10	moderate	G92823JK	28
IgG	Patient 1	22	moderate	G92823JK	29
IgM	Patient 1	10	moderate	G92823JK	55
IgM	Patient 1	22	moderate	G92823JK	60
IgG	Patient 1	6	moderate	G92823JK	27
IgM	Patient 1	6	moderate	G92823JK	50
IgA	Patient 2	15	mild	G92823JK	293
IgA	Patient 2	24	mild	G92823JK	345
IgG	Patient 2	15	mild	G92823JK	31
IgG	Patient 2	24	mild	G92823JK	32
IgM	Patient 2	15	mild	G92823JK	74
IgA	Patient 2	3	mild	G92823JK	342
IgG	Patient 2	3	mild	G92823JK	32
IgM	Patient 2	24	mild	G92823JK	82
IgM	Patient 2	3	mild	G92823JK	92
IgA	Patient 3	-180	mild	G92823JK	261
IgA	Patient 3	11	mild	G92823JK	355
IgG	Patient 3	-180	mild	G92823JK	51
IgM	Patient 3	-180	mild	G92823JK	92
IgA	Patient 3	4	mild	G92823JK	453
IgG	Patient 3	11	mild	G92823JK	55
IgG	Patient 3	4	mild	G92823JK	68